Robert Watson

6PUBLICATIONS
31CO-AUTHORS
Innate immunityGene expression (incl. microarray and other genome-wide approaches)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 07, 2026
Anti-CMV IgG titer determines organ-specific protection toward immune checkpoint blockade-induced toxicities.

|Jul 25, 2025
Defining the genetic determinants of CD8+ T cell receptor repertoire in the context of immune checkpoint blockade.

Esther S Ng, Gusztav Milotay, Orion Tong

|Jan 19, 2023
IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells.

Julie M Mazet, Jagdish N Mahale, Orion Tong

|Oct 01, 2021
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity.

Robert A Watson, Orion Tong, Rosalin Cooper

|Mar 28, 2020
Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice.

Isabel Tol, Elspeth Cumber, Daphne Nakakande

|Sep 13, 2019
Tumor heterogeneity: does it matter?

Casmir Turnquist, Robert A Watson, Andrew Protheroe

Pageof 1

Frequent Collaborators

4 joint publications

Orion Tong

3 joint publications

Chelsea A Taylor

3 joint publications

Benjamin P Fairfax

2 joint publications

Martin Little